PRUEBA RÁPIDA PARA LA DETECCIÓN DE ANTICUERPOS CONTRA EL SARS-COV-2
Mexico·Clase II·III. Agentes de
diagnóstico·PRODUCTOS ROCHE, S.A.
DE C.V.·Registered March 05, 2024- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- SARS-COV-2 RAPID ANTIBODY TEST
- Trade Name (English)
- SARS-COV-2 RAPID ANTIBODY TEST
- Analysis ID
- 0617R2024 SSA
- Registration Date
- March 05, 2024
- Name (Spanish)
- PRODUCTOS ROCHE, S.A. DE C.V.
- Name (English)
- PRODUCTOS ROCHE, S.A. DE C.V.
Access comprehensive regulatory information for PRUEBA RÁPIDA PARA LA DETECCIÓN DE ANTICUERPOS CONTRA EL SARS-COV-2 (PRUEBA RÁPIDA PARA LA DETECCIÓN DE ANTICUERPOS CONTRA EL SARS-COV-2) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 0617R2024 SSA and manufactured by PRODUCTOS ROCHE, S.A. DE C.V.. The device was registered on March 05, 2024.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.